No single antiepileptic drug (AED) is appropriate in all clinical situations and therapeutic decisions on the selection of the appropriate AED should be made on a variety of specific factors. Pharmacokinetics has an important role to play in the clinical practice of antiepileptic drug therapy, as it is important in estimating individualised drug dosage regimens necessary to achieve drug plasma concentrations without causing unacceptable toxicity.peer-reviewe
The new-AEDs, whose developments were motivated following the discovery of the valproate and its mar...
Epilepsy is one of the most common neurological disorders, with approximately 45 per 100,000 childre...
AbstractPurposeAs pharmacists play an important role in managing antiepileptic drug (AED) therapy, t...
In this paper an overview will be given of how knowledge of pharmacokinetic mechanisms determines wh...
Item does not contain fulltextLong-term anti-epileptic drug (AED) therapy is the reality for the maj...
In recent years, the number of commercially available antiepileptic drugs (AEDs) has increased stead...
Epilepsy is a chronic disease occurring in approximately 1.0% of the world's population. About 3...
Selecting the most appropriate antiepileptic drug (AED) or combination of drugs for each patient and...
Adverse antiepileptic drug interactions may occur at pharmacokinetic and pharmacodynamic level. �he ...
Although no randomized studies have demonstrated a positive impact of therapeutic drug monitoring (T...
The choice of an antiepileptic drug (AED) is usually based upon the epileptic seizure type. However,...
Whereas ongoing efforts in epilepsy research focus on the underlying disease processes, the lack of ...
Antiepileptic drugs (AEDs) are commonly prescribed for long periods, up to a lifetime, and many pati...
Epilepsy is a chronic disease; 30% of epileptic patients take more than one antiepileptic drug (AED...
Antiepileptic drugs (AEDs) are characterized by a narrow therapeutic index, requiring tailoring of t...
The new-AEDs, whose developments were motivated following the discovery of the valproate and its mar...
Epilepsy is one of the most common neurological disorders, with approximately 45 per 100,000 childre...
AbstractPurposeAs pharmacists play an important role in managing antiepileptic drug (AED) therapy, t...
In this paper an overview will be given of how knowledge of pharmacokinetic mechanisms determines wh...
Item does not contain fulltextLong-term anti-epileptic drug (AED) therapy is the reality for the maj...
In recent years, the number of commercially available antiepileptic drugs (AEDs) has increased stead...
Epilepsy is a chronic disease occurring in approximately 1.0% of the world's population. About 3...
Selecting the most appropriate antiepileptic drug (AED) or combination of drugs for each patient and...
Adverse antiepileptic drug interactions may occur at pharmacokinetic and pharmacodynamic level. �he ...
Although no randomized studies have demonstrated a positive impact of therapeutic drug monitoring (T...
The choice of an antiepileptic drug (AED) is usually based upon the epileptic seizure type. However,...
Whereas ongoing efforts in epilepsy research focus on the underlying disease processes, the lack of ...
Antiepileptic drugs (AEDs) are commonly prescribed for long periods, up to a lifetime, and many pati...
Epilepsy is a chronic disease; 30% of epileptic patients take more than one antiepileptic drug (AED...
Antiepileptic drugs (AEDs) are characterized by a narrow therapeutic index, requiring tailoring of t...
The new-AEDs, whose developments were motivated following the discovery of the valproate and its mar...
Epilepsy is one of the most common neurological disorders, with approximately 45 per 100,000 childre...
AbstractPurposeAs pharmacists play an important role in managing antiepileptic drug (AED) therapy, t...